Amin Hajitou
Has grant
Professor of Targeted Therapeutics
United KingdomResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Amin Hajitou is a Professor of Targeted Therapeutics at Imperial College London, UK. His research focuses on innovative cancer therapies, particularly the use of bacteriophage-based particles for targeted delivery of therapeutic agents and nucleic acids to tumors. Recent work includes the development of treatments for chondrosarcoma and pediatric medulloblastoma, as well as advancements in imaging techniques for glioma detection.
Recent Grants
Grant: Close
Investigation of a harmless prokaryotic viral vector for targeted intravenous cytokine gene therapy of cancer
Open Date: 2018-07-01
Close Date: 2022-06-01
Grant: Close
Targeting intracranial glial tumours established in mice from primary GBM explants by using novel bacteriophage nanoparticles and ADI-PEG20 therapy
Open Date: 2013-06-01
Close Date: 2018-05-01
Grant: Close
Design of superior phage delivery systems
Open Date: 2013-03-01
Close Date: 2014-01-01
Grant: Close
Targeting intracranial glial tumours established in mice from primary GBM explants by using novel bacteriophage nanoparticles and ADI-PEG20 therapy
Open Date: 2012-04-01
Close Date: 2013-05-01
Grant: Close
Mammalian cell transduction by bacteriophage
Open Date: 2010-04-01
Close Date: 2011-09-01
Articles (10)
Year:
2024
Year:
2024
Year:
2023
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (4)
Louis Allott
Lecturer in Translational Radiopharmaceutics
University of Hull
Keittisak Suwan
Imperial College London
Emmanuel Dias-Neto
Visiting professor
Rutgers Cancer Institute of New Jersey
Vessela Vassileva
Imperial College London
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.